ArticleChemistry & biology2015

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.

Peter Canning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.